Subramanian Hariharan, MD, FACP
Dr. Subramanian Hariharan is a Global Medical Director on the Oncology team at Pfizer. Dr. Hariharan has worked at Pfizer for 10 years and has participated in research studies and multicenter trials focused on the treatment of metastatic renal cancer for the past 8 years.
Prior to joining Pfizer, he was Director of Neuro-Oncology at New Jersey Neuroscience Center at JFK Medical Center, where he cared for patients with metastatic and primary brain tumors and conducted various clinical trials. He trained as a neuro-oncologist at Memorial Sloan Kettering Cancer Center in NY.